Shares of Capricor Therapeutics CAPR gained 8.4% on Thursday following the completion of the submission of a biologics ...

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology firm specializing in innovative cell and exosome-based therapies for rare diseases, finalized the submission of its Biologics License ...

Competition Commission of India has commenced the study on AI and competition that is expected to be completed by mid-2025 ...

A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration. Researchers have discovered that an experimental compound ...

A novel drug holds promise for treating Duchenne muscular dystrophy (DMD), a rare genetic disorder that causes severe muscle degeneration. McGill University researchers have discovered that an ...

The LDC project provides a portable D programming language compiler with modern optimization and code generation capabilities. The compiler uses the official DMD frontend to support the latest version ...

Credit: AnnGaysorn/Shutterstock. China’s National Medical Products Administration (NMPA) has approved Santhera Pharmaceuticals’ AGAMREE (vamorolone), used to treat Duchenne muscular dystrophy (DMD) in ...

Founded in 2013, DMD Diamond is a decentralized blockchain project that prioritizes community-driven governance and technological innovation. Over its decade-long history, the platform has maintained ...

Founded in 2013, DMD Diamond is a decentralized blockchain project that prioritizes community-driven governance and technological innovation. Over its decade-long history, the platform has maintained ...

Notably, the study identified seven loci with X-chromosome-wide significance thresholds that may contribute to AD-associated genes (e.g., FRMPD4, DMD, and WNK3), which were highlighted as ...